Zoomedia Blog

Our clients know that the litany of negative headlines from the financial sector in the past month has not escaped the eyes and minds of marketing departments budget crunchers throughout the life sciences. In response to the economic uncertainty, many biotech and pharma companies are cutting non-core spending to maintain internal stability. Reduced budgets present the proverbial challenge that "tools are needed to build a ship." Yet marketers are charged with delivering the corporate or product message out, building sales and partnerships, and developing brand awareness. In this catch-22, how can the industry best stretch its marketing dollars?

Tags: SEM, RSS, Online Marketing, Viral Marketing, Product Strategy, Investor Strategy, Clinical Trial Strategy

Many of our clients have asked us recently about “Web 2.0” technologies. Pharma DTC websites are beginning to see lively discussion around this topic and the technological advances behind the terminology are significant. Web 2.0, and all that the label stands for, indicates a major directional shift in online communication between all the stakeholders involved in DTC and DTP promotion. There is a significant patient empowerment movement emerging fueled by Web 2.0 that biotech and pharma cannot afford to ignore. This month we will address the Health 2.0 movement, its associated Web 2.0 terminology and technologies, and weigh-in on the debate many Biotechnology and Pharmaceutical companies are having about how, or whether, to best use these technologies. This is a very new form of communication particularly as applied to DTC promotion. In coming months, we will be publishing a series of articles and newsletters around social networking as it relates to our highly-regulated industry and the Health 2.0 movement.

Tags: Patient Strategy, Global Strategy, Product Strategy, Transforming Technology, Web 2.0